Tom,
You've said this before. Do you have any support for this? I've found nothing in the guidelines and nothing from Abbott labs about this "change". My surgery was just 3 years ago and I was given a target of 2.0 to 3.0. I am aware that your cardiologist had you switch from 2.0 to 3.0 to 2.0 to 2.5, but this does not mean the guidelines changed. Perhaps this was specific for you, as you have had issues with bleeding, if I recall correctly.
To be clear, I'm not trying to argue about this, but would like to see the support that the guidelines have changed, if they truly changed. Can you provide this? A letter from Abbott perhaps?
Also, I am personally very comfortable keeping my INR in the range of 2.0 to 2.5. There was a study published a few years back suggesting that this range is safe for St Jude, but, to my knowledge, this did not lead to a change in the guidelines.
Edit:
I just looked into the guidelines and I believe that your statement about the guidelines being lowered for the St Jude valve is incorrect.
You indicated that for St Jude the guidelines changed about 10 years ago. from the range of 2.0 - 3.0 to the range of 2.0 - 2.5. To my knowledge, 2020 was the last time that the guidelines addressed INR for mechanical valves. As of 2020, the target had not been lowered to the range of 2.0-2.5, as you suggest happened 10 years ago. Please see the link to the 2020 ACC/AHA Heart Valve Guidelines below:
"
For mechanical bileaflet or current-generation single-tilting disk AVR with no risk factors: INR of 2.5."
"For mechanical On-X AVR and no thromboembolic risk factors: A lower INR of 1.5-2.0, starting 3 months after surgery with addition of aspirin (ASA) 75-100 mg daily (Class 2b)."
https://www.acc.org/Latest-in-Cardi...0/12/16/22/01/2020-ACC-AHA-VHD-GL-Pt-3-GL-VHD